{
  "docId": "019de073-8d45-7608-905c-741cc65d0847",
  "docSlug": "b16516ae093225c5834bc86ab14054bf",
  "documentTitle": "LumiraDx | Investor Presentation Deck | 55 slides",
  "authorId": "lumiradx",
  "authorName": "LumiraDx",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 27,
  "pageCount": 55,
  "prevPage": 26,
  "nextPage": 28,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "balanced",
  "nDataPoints": 24,
  "notes": "The slide uses a blue dashed box to highlight key differentiators for the company's product.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-8d45-7608-905c-741cc65d0847/27",
  "deckHref": "/decks/019de073-8d45-7608-905c-741cc65d0847",
  "deckJsonHref": "/decks/019de073-8d45-7608-905c-741cc65d0847.json",
  "deckAnchorHref": "/decks/019de073-8d45-7608-905c-741cc65d0847#slide-27",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.2,
        "y": 0.9
      },
      "kind": "disclaimer",
      "text": "(1) Based on our current assumptions, including (a) the existing market sizes, (b) central lab market that could move to POC; and (c) expansion of diagnostic testing. (2) Based on respective company product specifications.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb0a55ad-d9e6-460e-bcff-8c72ebefce15",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.15,
        "x": 0.8,
        "y": 0.93
      },
      "kind": "legend",
      "text": "Key differentiator",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab662fd8-2010-47d1-861f-6792ce600ca3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.88,
        "x": 0.06,
        "y": 0.23
      },
      "kind": "table",
      "text": "Comparison table of True POC Needs vs Lab Reference and POC competitors across 8 metrics.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0c1a3b00-67f9-44a5-8915-a9eb9c623ad9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.1,
        "y": 0.05
      },
      "kind": "title",
      "text": "Unmet Need for High Sensitivity Troponin POC Test with a ~$900M Addressable Market",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6682d0c4-3cdc-4db8-b305-8d3f419beb46",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "07167fb3-fba8-474f-b88f-d48202e5a88f",
      "evidence": "table/data: Comparison table of True POC Needs vs Lab Reference and POC competitors across 8 metrics.",
      "confidence": 0.5
    },
    {
      "name": "Comparison frame",
      "slug": "comparison-frame",
      "agent": null,
      "layer": "slide",
      "matchId": "56657314-8d16-49ea-9dde-2ec5b821082b",
      "evidence": "Comparison table of True POC Needs vs Lab Reference and POC competitors across 8 metrics.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 30,
      "from": 25,
      "beatId": "bd378a21-72ee-4511-8b21-1eeaa66f3ac6",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "Slides 25-30 present real-world evidence supporting LumiraDx's COVID antigen test molecular-like performance and other testing capabilities",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}